PATENT CLAIM ANALYSIS

Application Number: 16023102
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Claim (Index 50):
The pharmaceutical composition according to  claim 39 , comprising:\n (i) from 18 to 22 parts of a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; and (ii) from 78 to 82 parts of d-alpha-tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS); wherein both parts are by weight and the sum of the parts (i)+(ii)=100; and wherein the hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide is dispersed within the Vitamin E TPGS and the composition is semi-solid or solid at ambient temperature.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.37838
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13463499', '14698151', '13391440', '14197476', '13414369']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7219797274805797
- 35 USC 102 Novelty (BERT): 0.491912444609026
- Combined Prediction Score: 0.6989729991934244
- Mean Citation Score: 219.52810600000004
- Max Citation Score: 251.7257
- Similarity Product: 202.5195032255292

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test